MoonLake Immunotherapeutics (MLTXN.MX) Q3 2025 Earnings

5AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-16.29
-13.73
-11.18
-8.62

Details

Expected EPS
-13.862356854
Actual EPS
-16.289271
Surprise EPS
-2.43
Surprise Percent
+17.51%

Description

MoonLake Immunotherapeutics (MLTXN.MX) has reported earnings of -16.289271 per share for Q3 2025.

0 Comments

Share your thoughts